Open AccessAn altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity
Author(s) -
Esther Nistal,
Luis E. Sáenz de Miera,
Maria D. BallesterosPomar,
Sonia Sánchez-Campos,
María Victoria GarcíaMediavilla,
Begoña Álvarez-Cuenllas,
Pedro Linares,
J.L. Olcoz,
María Teresa Arias-Loste,
Juan M. Garcı́a-Lobo,
Javier Crespo,
Javier GonzálezGallego,
Francisco Jorquera
Publication year - 2019
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2019.6068/2018
Subject(s) - dysbiosis , medicine , firmicutes , gut flora , fatty liver , gastroenterology , disease , microbiome , obesity , akkermansia , lactobacillus , bioinformatics , biology , immunology , 16s ribosomal rna , bacteria , genetics
increasing evidence suggests a role of intestinal dysbiosis in obesity and non-alcoholic fatty liver disease (NAFLD). The advances in recent years with regard to the role of the gut microbiota raise the potential utility of new therapeutic approaches based on the modification of the microbiome.